-- U.S. RESEARCH ROUNDUP: Facebook, Microsoft, American Express    
-- 
-- Fri Jan 10, 2014 05:40AM EST
-- None



Jan 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Facebook and Microsoft, on Friday.

HIGHLIGHTS * American Express <AXP.N>: Barclays ups target to $93 from $83; rating equal weight  * Facebook <FB.O>: Stifel raises price target to $65; rating buy * Microsoft <MSFT.O>: Barclays raises to overweight from equal weight * Vale SA <VALE.N>: Jefferies starts with hold; price target $15  Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.   * Abercrombie & Fitch <ANF.N>: Susquehanna raises target to $46 from $43; rating positive * Aegerion Pharmaceuticals <AEGR.O>: Cowen cuts target to $95 from $105; rating outperform * Affiliated Managers <AMG.N>: KBW raises target price to $230 from $214  * Alexion Pharmaceuticals <ALXN.O>: Barclays ups target to $141 from $127;rating overweight  * Alliancebernstein Holding <AB.N>: KBW raises target price to $25 from $24  * Allied Nevada Gold <ANV.A>: Cowen cuts target to $5.37 from $5.71; rating market perform  * American Express <AXP.N>: Barclays ups target to $93 from $83; rating equal weight  * American Financial <AFG.N>: KBW raises target to $61 from $60; rating market perform  * Ambarella <AMBA.O>: Deutsche Bank cuts to hold from buy  * Ambarella <AMBA.O>: Deutsche Bank raises price target to $32 from $28 * Artisan Partners Asset <APAM.N>: KBW ups target to $70 from $62; rating market perform  * Atricure <ATRC.O>: Canaccord Genuity raises price target to $25 from $19; rating buy * Biomarin Pharmaceutical <BMRN.O>: Barclays cuts to equal weight from overweight * Biomarin Pharmaceutical <BMRN.O>: Barclays cuts price target to $73 from $75  * Blackrock Inc <BLK.N>: KBW raises target price to $342 from $310; rating market perform * Cache Inc <CACH.O>: B.Riley resumes coverage with buy; price target $9.25 * Calamos Asset Management <CLMS.O>: KBW raises price target to $11 from $9.75 * Calamos Asset Management <CLMS.O>: KBW rating market perform  * Celgene Corp <CELG.O>: Barclays raises price target to $182 from $173; rating overweight  * Citrix Systems <CTXS.O>: Jefferies raises price target to $72 from $70; rating buy  * Cornerstone Ondemand <CSOD.O>: Barclays ups target to $65 from $60; rating overweight * CTC Media Inc <CTCM.O>: UBS starts with neutral; price target $14 * Discover Financial Services <DFS.N>: Barclays ups target to $63 from$59;rating overweight * E2open <EOPN.O>: Canaccord Genuity raises price target to $28 from $24; rating buy * Exfo Inc <EXFO.O>: CIBC cuts to sector underperformer from sector performer  * Exfo Inc <EXFO.O>: CIBC cuts price target to $4 from $4.50 * Facebook <FB.O>: Stifel raises price target to $65; rating buy * Federated Investors <FII.N>: KBW raises target to $29 from $28; rating market perform  * Fireeye Inc <FEYE.O>: Barclays raises price target to $65 from $56; rating overweight  * Five Below <FIVE.O>: Sterne Agee cuts price target to $45 from $56; rating buy * Five Below <FIVE.O>: Jefferies cuts price target to $48 from $51; rating buy * Franklin Resources <BEN.N>: KBW raises target price to $66 from $62; rating outperform  * Goldcorp <GG.N>: BMO cuts price target to $32 from $37; ratingoutperform * Goodrich Petroleum <GDP.N>: Imperial capital ups target to $22 from $18; rating in-line * Halozyme Therapeutics <HALO.O>: Barclays ups target to $15 from $12; rating equal weight  * Idenix Pharmaceuticals <IDIX.O>: Barclays ups target to $5 from $4; rating equal weight  * Incyte Corp <INCY.O>: Barclays raises to overweight from equal weight * Incyte Corp <INCY.O>: Barclays raises price target to $64 from $36 * InterMune <ITMN.O>: UBS raises price target to $19 from $15; rating buy * Invesco Ltd <IVZ.N>: KBW raises price target to $42 from $39; rating outperform  * Janus Capital <JNS.N>: KBW ups target to $11.25 from $9.75; rating market perform * Lattice Semiconductor <LSCC.O>: Jefferies raises target to $6.50 from $5.50; rating buy * Legg Mason <LM.N>: KBW raises price target to $48 from $42; rating market perform  * Manning & Napier <MN.N>: KBW raises price target to $20 from $19; rating market perform  * Medivation <MDVN.O>: Barclays raises price target to $62 from $57; rating equal weight * Microsoft <MSFT.O>: Barclays raises to overweight from equal weight * Microsoft <MSFT.O>: Barclays raises price target to $42 from $35   * On Assignment <ASGN.N>: Deutsche Bank raises price target to $39 from $37; rating hold * Qlik Technologies <QLIK.O>: Jefferies raises to buy from hold * Qlik Technologies <QLIK.O>: Jefferies raises target price to $35 from $29 * Regeneron Pharmaceuticals <REGN.O>: Barclays ups target to $340;rating overweight  * Roundy's Inc <RNDY.N>: Jefferies starts with hold; price target $10.50 * Servicenow <NOW.N>: Barclays raises price target to $65 from $60; rating overweight  * Splunk Inc <SPLK.O>: Barclays cuts to equal weight from overweight  * SunTrust Banks <STI.N>: Goldman Sachs adds to conviction-list buy * Tetraphase Pharmaceuticals <TTPH.O>: Barclays ups target to $17from $16;rating overweight * Triangle Capital <TCAP.N>: KBW raises to outperform from market perform * Tonix Pharmaceuticals <TNXP.O>: Roth raises price target to $17 from $18.50; rating buy * T. Rowe Price <TROW.O>: KBW raises price target to $90 from $80; rating market perform  * United Continental Holdings <UAL.N>: Imperial Capital ups target to $49;rating outperform * Vale SA <VALE.N>: Jefferies starts with hold; price target $15 * VMware Inc <VMW.N>: Jefferies raises price target to $114 from $102; rating buy * Waddell & Reed Financial <WDR.N>: KBW ups target to $68 from $64; rating market perform  * Zumiez Inc <ZUMZ.O>: Jefferies cuts price target to $24 from $27; rating holdSECTOR CHANGES: